Summary: Fifty drugs, applied in the therapy of internal diseases, were investigated for their effect on the clinical chemical determination of serum glucose by the automated GOD-Perid method. The results showed a statistically significant depression of the reported glucose value, by 7 drugs containing the pyrazolone group and its derivates (Baralgin, Butazolidine, Analgin, Novalgetol, Analgocain, Irgapyrin, Aminopyrin) P < 0.001; P < 0.01. The influence depends on the quantity of drug and on the time interval between loading and glucose analysis.
Introduction
Clinical chemical data for blood glucose, determined with specific glucose-oxidase reactions, are influenced by ascorbic acid (1, 2), hydrogen-peroxide and hypochlorite (3), diuretics and some other drugs (4) . The interference of the sulphonylureä drugs, Tolazamide and Tolbutamide, in the determination of glucose by the GOD-Perid method has been described (5, 6) , and it is a consequence of the lack of specificity of the final chromogen color reaction of this analytical procedure. Reducing substances either compete with the chromogen for H^C^ or keep it in reduced state leading to low glucose values (6) . With regard to published data (1) (2) (3) (4) (5) (6) and to our observation on the serum gjucose depressing effect of Baralgin, the aim of this work was to investigate drugs, applied in the therapy of internal diseases, for their possible influence on serum glucose data, estimated with the GOD-Perid method. Simultane* ously the influence of drugs on serum urea data was investigated.
Material and Methods
The analyses were performed in clear, nonhemolyzed, fasting sera and in glucose water solutions before and after in vitro loading with each of the 50 drugs listed in table 1. Most of the investigated drugs were in solution for intravenous application, except the oral tablet drugs Tolbusal, Meldian, Buformin, Daonil and Thyralette. The loading of sera and glucose solution 5.55 mmol/1 (100 mg/dl) was performed by dilution of the ampule contents with serum in the proportions found in 3000 ml plasma 3 min after intravenous application, or by suspending 1 pulverized tablet in 3000 ml serum. Parallel analyses of glucose in unloaded and drug-loaded material were performed on the Autoanalyzer I Technicon with the GODPerid ABTS test 1 ), where in the final colorimetric reaction the redox chromogen indicator ABTS (2,2'-AzUMMlH3-ethyl-benzthiazoline-6-sulphonic acid)) (7) crease in the measured value for serum glucose. Since Baralgin showed the greatest effect ( fig. 1) , further experiments were performed with 85 mg Baralgin per 100 ml of serum or glucose solution. Statistical evaluation of 32 serum glucose data before (x ± s = 4.94 ± 1.17 rhmol/1) and 30 min after loading (x ± s = 0.79 ± 0.62 mmol/1) demonstrated a statistically significant glucose depressing effect of Baralgin of (P < 0.001).
The difference between mean glucose values in unloaded and Baralgin-loaded sera was 4.15 mmol/1 glucose.
The difference between mean glucose data for glucose solutions of 5.55,11.11,16.65, and 22.22 mmol/1 before and after Baralgin-loading was found to be 2.89 mmol/1. 
Discussion
In this work it was showed that 7 drugs, containing pyrazolone or derivates lead to a decrease in the reported value for serum glucose, investigated with the GOD-Perid ABTS method. These drugs contain the hydrazine-N-N-group, which might have an acceptor function for the oxygen (5) derived from H 2 02 in the GOD-Perid ABTS analytic procedure, and possibly inhibit the chromogen ABTS reaction. The effect depends upon the drug concentration in the serum, the time interval between drug-loading and glucose analysis, and probably on the type of substituent in the pyrazolone. These findings are in accordance with published data on the glucose depressing effect of drugs with a hydrazine group in close proximity to benzene nucleus (5) . Some drugs might compete with the chromogen for H 2 0 2 or keep it in reduced state, leading to GOD-POD reactions that are not specific for the glucose determination (6).
Our findings show that some unpublished pyrazolone drugs, depress GOD-Perid serum glucose values, and complete the list of other drugs with a similar effect described earlier (1) (2) (3) (4) (5) (6) . The interaction of ascorbic acid, in amounts greater than 16.6 mg in 100 ml serum, with glucose data is confirmed in this work, although no interference by amounts less than 5.0 mg ascorbic acid in 100 ml sera was observed earlier (9) .
